Literature DB >> 31560106

The Role of Surgery in Meningiomas.

Michele Bailo1, Filippo Gagliardi2, Nicola Boari2, Antonella Castellano3, Alfio Spina2, Pietro Mortini2.   

Abstract

PURPOSE OF REVIEW: This review presents the most recent evidences and recommendations in the pre-, intra-, and post-surgical management of patients harboring meningiomas. Due to the increasing relevance of multimodal approaches, in order to preserve patients' neurological function and quality of life (QoL), the role of observation and radiation treatments (as either primary or adjuvant therapy) has also been discussed. RECENT
FINDINGS: Multiple advances in neurosurgery, including the use of the microscope and endoscope, improved preoperative neuroimaging, intraoperative image-guided approaches, and intraoperative neurophysiological monitoring, have extended the neurosurgeon's ability to remove lesions that were previously considered only partially resectable or unresectable, while minimizing morbidity. On the other hand, the preservation of patients' neurological integrity and QoL are increasingly important issues, more than complete tumor resection, for both patients and neurosurgeons. In this setting, stereotactic radiosurgery (SRS) and radiotherapy (RT) may be considered safe and effective alternatives for asymptomatic small- to moderate-sized tumors that demonstrate growth on serial imaging, or in combination with planned subtotal resection (STR) for tumors in critical locations. Data supporting the use of pharmacotherapy in meningiomas are, to date, weak, but the strength of the evidence might improve in the next future with the identification of targetable mutations. Complete microsurgical resection remains the standard of care if it can be achieved with minimal or no morbidity. However, many studies have reported SRS/RT as safe and effective treatments, either as primary approach or as complementary to surgery, especially when dealing with critically located meningiomas (e.g., cranial base) or in patients with comorbidity or wishing to avoid invasive treatments. The management of meningiomas is a field of complementary disciplines: neurosurgeon needs to work closely with radiation oncologists while tailoring the optimal treatment for these patients in order to achieve the best results.

Entities:  

Keywords:  Gamma Knife; Management; Meningioma; Radiosurgery; Radiotherapy; Surgery

Year:  2019        PMID: 31560106     DOI: 10.1007/s11940-019-0587-9

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  57 in total

1.  "Wait-and-See" Strategies for Newly Diagnosed Intracranial Meningiomas Based on the Risk of Future Observation Failure.

Authors:  Eun Jung Lee; Jin Hoon Park; Eun Suk Park; Jeong Hoon Kim
Journal:  World Neurosurg       Date:  2017-08-24       Impact factor: 2.104

2.  The natural history of intracranial meningiomas.

Authors:  Soichi Oya; Seon-Hwan Kim; Burak Sade; Joung H Lee
Journal:  J Neurosurg       Date:  2011-01-21       Impact factor: 5.115

Review 3.  Petroclival meningiomas: Remaining controversies in light of minimally invasive approaches.

Authors:  Sâmia Yasin Wayhs; Guilherme Alves Lepski; Leonardo Frighetto; Gustavo Rassier Isolan
Journal:  Clin Neurol Neurosurg       Date:  2016-11-29       Impact factor: 1.876

4.  Surgical outcome in elderly patients with intracranial meningioma.

Authors:  Toshiyuki Amano; Akira Nakamizo; Yuhei Michiwaki; Satoshi Matsuo; Yutaka Fujioka; Shinji Nagata
Journal:  J Clin Neurosci       Date:  2018-07-18       Impact factor: 1.961

5.  Surgical outcomes after reoperation for recurrent skull base meningiomas.

Authors:  Stephen T Magill; David S Lee; Adam J Yen; Calixto-Hope G Lucas; David R Raleigh; Manish K Aghi; Philip V Theodosopoulos; Michael W McDermott
Journal:  J Neurosurg       Date:  2018-05-04       Impact factor: 5.115

Review 6.  The incidence of second brain tumors related to cranial irradiation.

Authors:  Gustavo Nader Marta; Erin Murphy; Samuel Chao; Jennifer S Yu; John H Suh
Journal:  Expert Rev Anticancer Ther       Date:  2014-12-06       Impact factor: 4.512

7.  Management of spheno-orbital en plaque meningiomas: clinical outcome in a consecutive series of 40 patients.

Authors:  Nicola Boari; Filippo Gagliardi; Alfio Spina; Michele Bailo; Alberto Franzin; Pietro Mortini
Journal:  Br J Neurosurg       Date:  2012-08-21       Impact factor: 1.596

8.  Clinical and radiological outcomes of proactive Gamma Knife surgery for asymptomatic meningiomas compared with the natural course without intervention.

Authors:  Kyung Hwan Kim; So Jeong Kang; Jung-Won Choi; Doo-Sik Kong; Ho Jun Seol; Do-Hyun Nam; Jung-Il Lee
Journal:  J Neurosurg       Date:  2018-05-01       Impact factor: 5.115

9.  The endoscopic endonasal approach is not superior to the microscopic transcranial approach for anterior skull base meningiomas-a meta-analysis.

Authors:  Ivo S Muskens; Vanessa Briceno; Tom L Ouwehand; Joseph P Castlen; William B Gormley; Linda S Aglio; Amir H Zamanipoor Najafabadi; Wouter R van Furth; Timothy R Smith; Rania A Mekary; Marike L D Broekman
Journal:  Acta Neurochir (Wien)       Date:  2017-11-10       Impact factor: 2.216

Review 10.  EANO guidelines for the diagnosis and treatment of meningiomas.

Authors:  Roland Goldbrunner; Giuseppe Minniti; Matthias Preusser; Michael D Jenkinson; Kita Sallabanda; Emmanuel Houdart; Andreas von Deimling; Pantelis Stavrinou; Florence Lefranc; Morten Lund-Johansen; Elizabeth Cohen-Jonathan Moyal; Dieta Brandsma; Roger Henriksson; Riccardo Soffietti; Michael Weller
Journal:  Lancet Oncol       Date:  2016-08-30       Impact factor: 41.316

View more
  2 in total

Review 1.  Review of Atypical and Anaplastic Meningiomas: Classification, Molecular Biology, and Management.

Authors:  Taylor Anne Wilson; Lei Huang; Dinesh Ramanathan; Miguel Lopez-Gonzalez; Promod Pillai; Kenneth De Los Reyes; Muhammad Kumal; Warren Boling
Journal:  Front Oncol       Date:  2020-11-20       Impact factor: 6.244

2.  Advances in meningioma genomics, proteomics, and epigenetics: insights into biomarker identification and targeted therapies.

Authors:  Ahmad A Nazem; Jacob Ruzevick; Manuel J Ferreira
Journal:  Oncotarget       Date:  2020-12-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.